Table 3.
Actors | Capability | Context | Coherence | Cognitive participation | Collective action | Reflexive monitoring |
---|---|---|---|---|---|---|
AMT |
Limitations on organisational support to resource / prioritise AMT work. Limited availability of technical solutions to support prescribing review. |
Constraints on AMT leadership engaging with all stakeholder groups. | Lack of provision of direct feedback of indicator audits to clinicians. | |||
Prescribing doctors | Lack of continuity in medical cover makes ongoing review of prescribing decisions challenging. | Medical hierarchies create limited ability to influence team norms or practices. | Lack of confidence to challenge consultant decisions. | No feedback on prescribing indicator audits, therefore no reflection on personal practice. | ||
Consultants or locum medical staff | Lack of provision of or engagement with AMS updates. | Competing issues impede prioritisation of AMS. | Lack of continuity of medical staff impedes ongoing AMS activity. | Limited feedback on prescribing indicator audits, therefore no reflection on personal practice. | ||
Nurses |
AMS often not viewed as a nursing role or responsibility. Limited opportunities for engagement. |
Lack of time and access to AMS training. | Lack of awareness of potential nurse’s role in AMS. |
Lack of engagement in AMS activities. Lack of confidence to question doctors’ decisions. |
||
Clinical Pharmacists | Resource constraints and role priorities which limit opportunities for AMS related activities. |